Saint Medical Technology key facts
as of Oct 2026- Developer of structural heart disease diagnosis and treatment technology platform and medical devices.
- Saint Medical Technology is valued at approximately $121.2M as of Oct 2026 (last reported valuation).
- It has raised $20.8M; the latest was Later Stage VC in Apr 2026.
- Notable investors include Wuxi Capital, Zijin Hi-Tech Venture Capital, Wuxi Jinkong Qiyuan Investment, GP Capital (Shanghai), InnoMed Capital — 11 tracked in total.
- Status: Privately Held (backing).
Saint Medical Technology's last reported valuation, Nov 2022. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch Saint Medical Technology: the Monday email on marks, rounds and moves
Saint Medical Technology funding rounds
No funding rounds for Saint Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Saint Medical Technology
11+Membership and data by Private Market View
Saint Medical Technology valuation
Saint Medical Technology's last reported valuation was $121 million in Nov 2022. No priced round, secondary trade or fund mark has surfaced since.
Saint Medical Technology investors
11 investors are on record for Saint Medical Technology, including Wuxi Capital, Zijin Hi-Tech Venture Capital, Wuxi Jinkong Qiyuan Investment and GP Capital (Shanghai).
About Saint Medical Technology
Developer of structural heart disease diagnosis and treatment technology platform and medical devices. The company is committed to building a diagnostic platform and developing innovative medical devices in the field of valvular heart disease, enabling patients with heart disease to get better treatment.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2019
- Employees
- 100
- Website
- saint-medical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.